Order Article Reprints

Yoshimoto M, Washiyama K, Ohnuki K, Doi A, Inokuchi M, Kojima M, Miller BW, Yoshii Y, Inaki A, Fujii H. Long-Term Therapeutic Effects of ²²⁵Ac-DOTA-E[c(RGDfK)]₂ Induced by Radiosensitization via G2/M Arrest in Pancreatic Ductal Adenocarcinoma. Pharmaceutics. 2025; 17(1):9. https://doi.org/10.3390/pharmaceutics17010009

Yoshimoto, Mitsuyoshi, Kohshin Washiyama, Kazunobu Ohnuki, Ayano Doi, Miki Inokuchi, Motohiro Kojima, Brian W. Miller, Yukie Yoshii, Anri Inaki, and Hirofumi Fujii. 2025. "Long-Term Therapeutic Effects of ²²⁵Ac-DOTA-E[c(RGDfK)]₂ Induced by Radiosensitization via G2/M Arrest in Pancreatic Ductal Adenocarcinoma" Pharmaceutics 17, no. 1: 9. https://doi.org/10.3390/pharmaceutics17010009

Yoshimoto, M., Washiyama, K., Ohnuki, K., Doi, A., Inokuchi, M., Kojima, M., Miller, B. W., Yoshii, Y., Inaki, A., & Fujii, H. (2025). Long-Term Therapeutic Effects of ²²⁵Ac-DOTA-E[c(RGDfK)]₂ Induced by Radiosensitization via G2/M Arrest in Pancreatic Ductal Adenocarcinoma. Pharmaceutics, 17(1), 9. https://doi.org/10.3390/pharmaceutics17010009